Share on

North America Microbiome Sequencing Services Market Research Report - Segmented By Technology, Application, Research Type, Laboratory Type, End User & Country (U.S, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2023 to 2028)

Published: March, 2023
ID: 7730
Pages: 145
Formats: report pdf report excel report power bi report ppt

North America Microbiome Sequencing Services Market Size & Growth (2023 to 2028):

As per the research report, the size of the North America Microbiome sequencing services market size is valued at USD 288.93 Million in 2023. It is expected to grow at a CAGR of 21.11% to reach USD 752.83 Million by 2028 during the forecast period 2023 to 2028.

The market growth in North America is being driven by greater use of microbiomes in genomics, proteomics, and metabolomics, and technological developments in next-generation sequencing (NGS). As a result, the North American region is expected to increase significantly during the forecast period.

The market is classified into four categories based on technology: sequencing by synthesis (SBS), sequencing by ligation (SBL), Sanger sequencing, and others. In 2021, the market for sequencing by synthesis was predicted to develop at the fastest rate. This high pace of growth can be ascribed to the massive demand for this technology.

Factors like increased demand for microbiome research, significant investment in next-generation sequencing, and lower cost of next-generation sequencing are driving the microbiome sequencing services market.

A microbiome is the billions of microorganisms that live in and on an individual's body. Microbiome sequencing is a diagnostic approach that involves sequencing millions or billions of DNA strands simultaneously.

Furthermore, prominent industry players are forming strategic alliances to maintain market dominance. Likewise, expanding applications of microbiome sequencing and an increase in genome mapping studies are moving the industry forward.

The shortage of experienced specialists, ethical and legal difficulties surrounding genome sequencing, and the unaffordability of microbiome sequencing services in some economies are hindering the market's growth to some extent.

On the other hand, the market is restricted by rigorous research, regulatory regulations, and ethical and legal considerations surrounding NGS.

This research report on the North America Microbiome Sequencing Services Market has been segmented and sub-segmented into the following categories:

By Technology:

  • sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Pyrosequencing
  • Sanger Sequencing
  • Others

By Application:

  • shotgun Sequencing
  • Targeted Gene Sequencing
  • RNA Sequencing
  • Whole Genome Sequencing
  • Others

By Research Type:

  • internal Research
  • Outsourced Research

By Laboratory Type:

  • Wet Lab
  • Dry Lab

By End User:

  • Pharmaceutical
  • Biotechnology

By Country:

  • U.S
  • Canada
  • Rest of North America

Geographically, the North America will likely dominate the worldwide microbiome sequencing services market due to growing per capita healthcare spending and the widespread embrace of new technologies. Additionally, higher R&D investments by healthcare organizations and the government are projected to move the market forward in this area.

The global microbiome sequencing services market in North America grew significantly. A well-established healthcare system and a rise in chronic diseases are driving market expansion in this area.

The high incidence of cancer in the United States is projected to raise demand for next-generation sequencing and monoclonal bodies and cellular research. These elements are projected to boost the market for microbiome sequencing services.

North America is expected to grow steadily during the forecast period, owing to the vast patient pool of chronic diseases and government healthcare reform efforts. Therefore, increased investments in mHealth products and preservation practices are the most critical factors for this region.

Furthermore, due to technological developments, NGS (Next-Gen Sequencing) to generate microbiome data has increased. Besides, techniques such as novel high-throughput sequencing and new software tools transform microbiome studies by providing service at high quality, speed, and high cost in this region.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Microbiome sequencing services market profiled in this report are Metabiomics Corp., Microbiome Therapeutics LLC, Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co., Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation, and Molecular Research LP.,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample